Sanum Sanguineas Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 1.00 M
as on 07-12-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.11 Cr
as on 07-12-2024
- Revenue 57.65%
(FY 2023)
- Profit 182.75%
(FY 2023)
- Ebitda 35.60%
(FY 2023)
- Net Worth 306.98%
(FY 2023)
- Total Assets 30.71%
(FY 2023)
About Sanum Sanguineas Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.11 Cr.
Ratan Dattatraya and Sridevi serve as directors at the Company.
- CIN/LLPIN
U74999TN2015PTC099300
- Company No.
099300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanum Sanguineas Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratan Dattatraya  | Director | 18-Feb-2015 | Current |
| Sridevi | Director | 18-Feb-2015 | Current |
Financial Performance of Sanum Sanguineas Solutions.
Sanum Sanguineas Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.65% increase. The company also saw a substantial improvement in profitability, with a 182.75% increase in profit. The company's net worth Soared by an impressive increase of 306.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanum Sanguineas Solutions?
Unlock access to Sanum Sanguineas Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vibhava Marketing Corporation Private LimitedActive 1 year 3 monthsRatan Dattatraya is a mutual person
Progressio Projects And Infrastructure Private LimitedActive 5 years 1 monthRatan Dattatraya is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 May 2019 | ₹6.12 M | Open |
Axis Bank Limited Creation Date: 20 Mar 2019 | ₹3.50 Cr | Open |
How Many Employees Work at Sanum Sanguineas Solutions?
Unlock and access historical data on people associated with Sanum Sanguineas Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanum Sanguineas Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanum Sanguineas Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
